Skip to main content
Year archive

ArcticZymes Technologies — 2020 filings

All 66 regulatory filings released by ArcticZymes Technologies (AZT) in 2020, sourced directly from the official regulator.

66 Filings
2020 Period
2020 filings (66)
Filing Released Lang
ArcticZymes Technologies announces closing of Biotec BetaGlucans divestment
M&A Activity
2020-12-31 English
ArcticZymes Technologies invitation to Q&A session around the Biotec Betaglucans divestment
Regulatory Filings
2020-12-14 English
ArcticZymes Technologies divests Biotec BetaGlucans subsidiary to Lallemand
M&A Activity
2020-12-14 English
ArcticZymes Technologies divests Biotec BetaGlucans subsidiary to Lallemand
M&A Activity
2020-12-14 English
ArcticZymes Technologies presents at Redeye R&D Tools Seminar
Investor Presentation
2020-11-10 English
ArcticZymes Technologies presents at Redeye R&D Tools Seminar
Report Publication Announcement
2020-11-10 English
Finansiell kalender
Report Publication Announcement
2020-11-03 Norwegian
Financial calendar
Report Publication Announcement
2020-11-03 English
ArcticZymes Technologies Q3 2020 Results
Interim / Quarterly Report Q3 2020
2020-10-22 English
ArcticZymes Technologies Q3 2020 Results
Earnings Release Q3 2020
2020-10-22 English
ArcticZymes Technologies Q3 2020 Results
Earnings Release Q3 2020
2020-10-22 English
ArcticZymes Technologies Q3 2020 Presentation
Interim / Quarterly Report Q3 2020
2020-10-22 English
ArcticZymes Technologies Q3 2020 Presentation
Investor Presentation
2020-10-22 English
ArcticZymes Technologies ASA: Invitation to presentation of Q3 2020 results
Report Publication Announcement
2020-10-16 English
ArcticZymes has entered into an agreement with Simcere Diagnostics to supply its HL-SAN product for Simcere's metagenomics sequencing tests
Regulatory Filings
2020-10-08 English
ArcticZymes has entered into an agreement with Simcere Diagnostics to supply its HL-SAN product for Simcere's metagenomics sequencing tests
Regulatory Filings
2020-10-08 English
ArcticZymes Technologies to present at Pareto Healthcare Conference
Investor Presentation
2020-09-02 English
ArcticZymes Technologies to present at Pareto Healthcare Conference
Investor Presentation
2020-09-02 English
ArcticZymes Technologies Q2 2020 Report
Interim / Quarterly Report Q2 2020
2020-08-19 English
ArcticZymes Technologies Q2 2020 Report
Earnings Release Q2 2020
2020-08-19 English
ArcticZymes Technologies Q2 2020 Report
Earnings Release Q2 2020
2020-08-19 English
ArcticZymes Technologies Q2 2020 Presentation
Investor Presentation Q2 2020
2020-08-19 English
ArcticZymes Technologies Q2 2020 Presentation
Report Publication Announcement
2020-08-19 English
ArcticZymes Technologies ASA: Invitation to presentation of Q2 2020 results
Report Publication Announcement
2020-08-13 English
ArcticZymes has entered into an agreement with ReiThera to supply its SAN product for ReiThera's COVID-19 vaccine candidate
Regulatory Filings
2020-07-02 English
ArcticZymes has entered into an agreement with ReiThera to supply its SAN product for ReiThera's COVID-19 vaccine candidate
Regulatory Filings
2020-07-02 English
Nytt navn og ny ticker fra og med 19.06.2020
Regulatory Filings
2020-06-19 Norwegian
New name and new ticker from 19.06.2020
Regulatory Filings
2020-06-19 English
Nytt navn og ny ticker fra og med 19.06.2020
Regulatory Filings
2020-06-18 Norwegian
New name and new ticker from 19.06.2020
Regulatory Filings
2020-06-18 English
Biotec Pharmacon ASA rebrands as ArcticZymes Technologies ASA
Regulatory Filings
2020-06-17 English
Biotec Pharmacon ASA rebrands as ArcticZymes Technologies ASA
Regulatory Filings
2020-06-17 English
ArcticZymes granted NOK 1.6 million funding from Innovation Norway for enzyme development project.
Capital/Financing Update
2020-05-28 English
ArcticZymes granted NOK 1.6 million funding from Innovation Norway for enzyme development project.
Regulatory Filings
2020-05-28 English
ArcticZymes granted NOK 1.65 million funding from Innovation Norway for a SAN-HQ upscaling project
Capital/Financing Update
2020-05-20 English
ArcticZymes granted NOK 1.65 million funding from Innovation Norway for a SAN-HQ upscaling project
Regulatory Filings
2020-05-20 English
Biotec Pharmacon - Minutes from Annual General Meeting
AGM Information
2020-05-14 English
Biotec Pharmacon - Minutes from Annual General Meeting
AGM Information
2020-05-14 English
Biotec Pharmacon - Flagging av fullmakter
AGM Information
2020-05-14 Norwegian
Flaggemelding Biotec Pharmacon
Director's Dealing
2020-05-12 Norwegian
Major shareholder disclosure in Biotec Pharmacon ASA
Major Shareholding Notification
2020-05-07 English
Major shareholder disclosure in Biotec Pharmacon ASA
Major Shareholding Notification
2020-05-07 English
Notification of major holdings
Major Shareholding Notification
2020-05-06 English
Notification of major holdings
Major Shareholding Notification
2020-05-06 English
Major shareholder disclosure in Biotec Pharmacon ASA
Major Shareholding Notification
2020-05-04 Norwegian
Major shareholder disclosure in Biotec Pharmacon ASA
Major Shareholding Notification
2020-05-04 English
Biotec Pharmacon ASA - Notice of Annual General Meeting
AGM Information
2020-04-23 Norwegian
Biotec Pharmacon ASA - Notice of Annual General Meeting
AGM Information
2020-04-23 English
Biotec Pharmacon Q1 2020 Presentation
Investor Presentation
2020-04-23 English
Biotec Pharmacon Q1 2020 Presentation
Investor Presentation
2020-04-23 English
Biotec Pharmacon Q1 2020 Report
Earnings Release Q1 2020
2020-04-23 English
Biotec Pharmacon Q1 2020 Report
Earnings Release Q1 2020
2020-04-23 English
Biotec Pharmacon ASA appoints Dr. Jethro Holter as CEO
Board/Management Information
2020-04-22 English
Biotec Pharmacon ASA appoints Dr. Jethro Holter as CEO
Board/Management Information
2020-04-22 English
Biotec Pharmacon ASA - Annual report 2019
Annual Report FY 2019
2020-04-21 English
Biotec Pharmacon ASA - Annual report 2019
Report Publication Announcement
2020-04-21 English
Biotec Pharmacon ASA: Invitation to presentation of Q1 2020 results
Report Publication Announcement
2020-04-20 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2020-02-12 English
Biotec Pharmacon Q4 2019 Presentation
Investor Presentation
2020-01-30 English
Biotec Pharmacon Q4 2019 Presentation
Report Publication Announcement
2020-01-30 English
Biotec Pharmacon Q4 2019 Report
Earnings Release Q4 2019
2020-01-30 English
Biotec Pharmacon ASA: Invitation to presentation of Q4 2019 results
Report Publication Announcement
2020-01-24 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2020-01-20 English
Biotec Pharmacon -  Minutes of Extraordinary General Meeting
AGM Information
2020-01-06 Norwegian
Biotec Pharmacon -  Minutes of Extraordinary General Meeting
AGM Information
2020-01-06 English
Biotec Pharmacon - Flagging av fullmakter
Proxy Solicitation & Information Statement
2020-01-06 Norwegian